Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Stephen O who wrote (8640)	11/19/2004 9:49:50 AM
From: Robohogs	Read Replies (2) \| Respond to of 9523

This is the same article as yesterday basically. No mention of Lipitor or Celebrex. Move on man! Stop the vendetta. Between you and Raymond, I am beginning to think it is me that is crazy. Jon

To: Stephen O who wrote (8640)	11/19/2004 4:02:39 PM
From: Casaubon	Respond to of 9523

But this more or less amounts to an admission that so-called blockbuster drugs just don't work because people's individual genetic make up aren't that uniform. In other words, different drugs for different people and that means the emergence of niche drug companies instead of the powerhouses we have now. This statement is only half correct. The markets will fragment as stated but, the companies will need to charge more money for each drug, since the price of clinical trials will not be any cheaper. So, expect much higher prices for drugs.